Shaelyn Ward
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shaelyn Ward has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Matt Vassar
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
5 shared publications - Alicia Ito Ford
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Garrett Jones
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Jay Modi
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, USA
4 shared publications - Kimberly Magana
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA
4 shared publications - Kyle Fitzgerald
Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA
4 shared publications
Latest Publications
- Open Access
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Assessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 15 August 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 41, 101347
Open AccessAssessing core outcome set uptake in randomized controlled trials for chronic kidney disease: Cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 5 June 2024
- Published by Springer Nature in Quality of Life Research
- Vol. 33 (8) , 2275-2283
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 7 January 2024
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 207, 111085
Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 27 September 2023
- Published by Elsevier in Ageing Research Reviews
- Vol. 91, 102081
Assessing uptake of the core outcome set in randomized controlled trials for Parkinson’s disease: A systematic review
- 21 June 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (7) , 531-542
Assessing the Reporting of Harms in Systematic Reviews Focused on Platelet-Rich Plasma Therapy: a Cross-SectionalAnalysis
Aim: Our objectives are: to evaluate the completeness of harms reporting in systematic reviews (SRs) on platelet-rich plasma therapy; to assess the overall methodological quality of the SR using AM... Plain language summary This study looked at how well the negative effects (harms) of platelet-rich plasma therapy are reported in systematic reviews (SRs). The researchers carefully reviewed and ex... Tweetable abstract Harms of platelet rich plasma therapy must be adequately evaluated and reported to provide patients with the best care possible. Of the 103 included systematic reviews, all SRs r...
- 21 June 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (7) , 531-542
Assessing the Reporting of Harms in Systematic Reviews Focused on Platelet-Rich Plasma Therapy: a Cross-SectionalAnalysis
Aim: Our objectives are: to evaluate the completeness of harms reporting in systematic reviews (SRs) on platelet-rich plasma therapy; to assess the overall methodological quality of the SR using AM... Plain language summary This study looked at how well the negative effects (harms) of platelet-rich plasma therapy are reported in systematic reviews (SRs). The researchers carefully reviewed and ex... Tweetable abstract Harms of platelet rich plasma therapy must be adequately evaluated and reported to provide patients with the best care possible. Of the 103 included systematic reviews, all SRs r...